Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 7/2018

Open Access 01-07-2018 | Original Article

First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study

Authors: Denis Agostini, Vincent Roule, Catherine Nganoa, Nathaniel Roth, Raphael Baavour, Jean-Jacques Parienti, Farzin Beygui, Alain Manrique

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 7/2018

Login to get access

Abstract

Purpose

We assessed the feasibility of myocardial blood flow (MBF) and flow reserve (MFR) estimation using dynamic SPECT with a novel CZT camera in patients with stable CAD, in comparison with 15O–water PET and fractional flow reserve (FFR).

Methods

Thirty patients were prospectively included and underwent FFR measurements in the main coronary arteries (LAD, LCx, RCA). A stenosis ≥50% was considered obstructive and a FFR abnormal if ≤0.8. All patients underwent a dynamic rest/stress 99mTc-sestamibi CZT-SPECT and 15O–water PET for MBF and MFR calculation. Net retention kinetic modeling was applied to SPECT data to estimate global uptake values, and MBF was derived using Leppo correction. Ischemia by PET and CZT-SPECT was considered present if MFR was lower than 2 and 2.1, respectively.

Results

CZT-SPECT yielded higher stress and rest MBF compared to PET for global and LAD and LCx territories, but not in RCA territory. MFR was similar in global and each vessel territory for both modalities. The sensitivity, specificity, accuracy, positive and negative predictive value of CZT-SPECT were, respectively, 83.3, 95.8, 93.3, 100 and 85.7% for the detection of ischemia and 58.3, 84.6, 81.1, 36.8 and 93% for the detection of hemodynamically significant stenosis (FFR ≤ 0.8).

Conclusions

Dynamic 99mTc-sestamibi CZT-SPECT was technically feasible and provided similar MFR compared to 15O–water PET and high diagnostic value for detecting impaired MFR and abnormal FFR in patients with stable CAD.
Literature
1.
Ben-Haim S, Murthy VL, Breault C, Allie R, Sitek A, Roth N, et al. Quantification of myocardial perfusion reserve using dynamic SPECT imaging in humans: a feasibility study. J Nucl Med. 2013;54:873–9.CrossRefPubMedPubMedCentral
2.
Ben Bouallègue F, Roubille F, Lattuca B, Cung TT, Macia JC, Gervasoni R, et al. SPECT myocardial perfusion reserve in patients with multivessel coronary disease: correlation with angiographic findings and invasive fractional flow reserve measurements. J Nucl Med. 2015;56:1712–27.CrossRefPubMed
3.
Nkoulou R, Fuchs TA, Pazhenkottil AP, Kuest SM, Ghadri JR, Stehli J, et al. Absolute myocardial blood flow and flow reserve assessed by gated SPECT with cadmium–zinc–telluride detectors using 99mTc-Tetrofosmin: head-to-head comparison with 13N-ammonia PET. J Nucl Med. 2016;57:1887–92.CrossRefPubMed
4.
Bergmann SR, Fox KA, Rand AL, Mc Elvany KD, Welch MJ, Markham J, et al. Quantification of regional myocardial blood flow in vivo with H215O. Circulation. 1984;70:724–33.CrossRefPubMed
5.
Bol A, Melin JA, Vanoverschelde JL, Baudhuin T, Vogelaers D, Pauw MD, et al. Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation. 1993;87:512–25.CrossRefPubMed
6.
Huang SC, Schwaiger M, Carson RE, Carson J, Hansen H, Selin C, et al. Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. J Nucl Med. 1985;26:616–25.PubMed
7.
Nesterov SV, Han C, Mäki M, Kajander S, Naum AG, Helenius H, et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging. 2009;36:1594–02.CrossRefPubMed
8.
Iida H, Yokoyama I, Agostini D, Banno T, Kato T, Ito K, et al. Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: a multicentre evaluation in Japan. Eur J Nucl Med. 2000;27:192–201.CrossRefPubMed
9.
Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med 2014;55:248-255.
10.
Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.CrossRefPubMed
11.
De Bruyne B, Pijls NH, Kalesan B, Barbato E, PAL T, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001.CrossRefPubMed
12.
Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Flore V, et al. Intracoronary adenosine: dose-response relationship with hyperemia. JACC Cardiovasc Interv. 2015;8:1422–30.CrossRefPubMed
13.
Bellevre D, Manrique A, Legallois D, Bross S, Baavour R, Roth N, et al. First determination of the heart-to-mediastinum ratio using cardiac dual isotope ((123)I-MIBG/(99m)Tc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study. Eur J Nucl Med Mol Imaging. 2015;42:1912–9.CrossRefPubMed
14.
Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765–74.CrossRefPubMed
15.
Leppo JA, Meerdink DJ. Comparison Of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. 1989;65:632–9.CrossRefPubMed
16.
Yoshida K, Mullani N, Gould KL. Coronary Flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37:1701–12.PubMed
17.
Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992;33:1243–50.PubMed
18.
Renaud JM, Dasilva JN, Beanlands RS, DeKemp RA. Characterizing the normal range of myocardial blood flow with 82rubidium and 13N-ammonia PET imaging. J Nucl Cardiol. 2013;20:578–91.CrossRefPubMed
19.
Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? JACC Cardiovasc Imaging. 2012;5:193–202.CrossRefPubMed
20.
Johnson NP, Gould KL, Di Carli MF, Taqueti VR. Invasive FFR and noninvasive CFR in the evaluation of ischemia. What is the future? JACC. 2016;67:2772–88.CrossRefPubMed
21.
ICRP. Radiation dose to patients from radiophamarceuticals. ICRP Publication 106. Ann ICRP 2008 38/1.
22.
Stabin MG. Radiopharmaceuticals For nuclear cardiology: radiation Dosimetry, uncertainties, and risk. J Nucl Med. 2008;49:1555–63.CrossRefPubMed
23.
Tuffier S, Legallois D, Belin A, Joubert M, Baillez A, Redonnet M, et al. Assessment of endothelial function and myocardial flow reserve using 15O-water PET without attenuation correction. Eur J Nucl Med Mol Imaging. 2016;43:285–95.CrossRef
24.
Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative O-15 H2O PET imaging. JACC. 2014;64:1464–75.CrossRefPubMed
25.
Kajander SA, Joutsiniemi E, Saraste M, Pietilä M, Ukkonen H, Saraste A, et al. Clinical value of absolute quantification of myocardial perfusion with (15) O-water in coronary artery disease. Circ Cardiovasc Imaging. 2001;4:678–84.CrossRef
26.
Taki J, Fujino S, Nakajima K, Matsunari I, Okazaki H, Saga T, et al. 99mTc-sestamibi retention characteristics during pharmacologic hyperemia in human myocardium: comparison with coronary flow reserve measured by Doppler flowire. J Nucl Med. 2001;42:1457–63.
27.
Ito Y, Katoh C, Noriyasu K, Kuge Y, Furuyama H, Morita K, et al. Estimation of myocardial blood flow and myocardial flow reserve by 99mTc-sestamibi imaging: comparison with the results of [15O]H2O PET. Eur J Nucl Med Mol Imaging. 2003;30:281–7.CrossRefPubMed
28.
Storto G, Soricelli A, Pellegrino T, Petretta M, Cuoculo A. Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches. Eur J Nucl Med Mol Imaging. 2009;36:2034–41.CrossRefPubMed
29.
Daniele S, Nappi C, Accampa W, Storto G, Pellegrino T, Ricci F, et al. Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography. J Nucl Cardiol. 2011;18:612–9.CrossRefPubMed
30.
Hsu B, Chen F-C, Wu T-C, Huang W-S, Hou P-N, Chen C-C, et al. Quantitation of myocardial blood flow and myocardial flow reserve with 99mTc-sestamibi dynamic SPECT/CT to enhance detection of coronary artery disease. Eur J Nucl Med Mol Imaging. 2014;41:2294–06.CrossRefPubMed
31.
Iida H, Eberl S. Quantitative Assessment of regional myocardial blood flow with thallium-201 and SPECT. J Nucl Cardiol. 1998;5:313–31.CrossRefPubMed
32.
Iida H, Eberl S, Kim K-M, Tamura Y, Ono Y, Nakazawa M, et al. Absolute quantitation of myocardial blood flow with 201Tl and dynamic SPECT in canine: optimisation and validation of kinetic modelling. Eur J Nucl Med Mol Imaging. 2008;35:896–905.CrossRefPubMed
33.
Klein R, Hung G-U, Wu T-C, Huang W-S, Li D, de Kemp RA, et al. Feasibility and operator variability of myocardial blood flow and reserve measurements with 99mTc-sestamibi quantitative dynamic SPECT/CT imaging. J Nucl Cardiol. 2014;21:1075–88.CrossRefPubMed
34.
Wells RG, Timmins R, Klein R, Lockwood J, Marvin B, de Kemp RA, et al. Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model. J Nucl Med. 2014;55:1–7.CrossRef
35.
Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med. 2009;50:1076–87.CrossRefPubMed
36.
De Bruyne B, Baudhuin T, Melin JA, Pijls NH, Sys SU, Bol A, et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with the positron emission tomography in the assessment of coronary artery stenoses. Circulation. 1994;89:1013–22.CrossRefPubMed
37.
Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech J-W, van’t Veer M, et al. Percutaneous coronary intervention of functionally non-significant stenosis: 5-year follow-up of the DEFER study. JACC. 2007;49:2105–11.CrossRefPubMed
38.
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;18:539–42.CrossRef
Metadata
Title
First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study
Authors
Denis Agostini
Vincent Roule
Catherine Nganoa
Nathaniel Roth
Raphael Baavour
Jean-Jacques Parienti
Farzin Beygui
Alain Manrique
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-3958-7

Other articles of this Issue 7/2018

European Journal of Nuclear Medicine and Molecular Imaging 7/2018 Go to the issue

Original Article

Optimal time-point for 68Ga-PSMA-11 PET/CT imaging in assessment of prostate cancer: feasibility of sterile cold-kit tracer preparation?

Original Article

Roles of posttherapy 18F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy

Original Article

18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer

Original Article

Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients

Original Article

PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy

Letter to the Editor

The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress